Google
×
The Investor Relations website contains ... Investor Overview. Latest News Releases. View All. 3/28/24 ... Stock Quote. NBIX (Common Stock). $137.92. Change. + ...
Neurocrine participates in industry conferences providing presentations on company updates & progress on research and development activities. Learn more.
Dec 14, 2021 · Neurocrine Biosciences, Inc. (Nasdaq: NBIX) financial results for the second quarter ended June 30, 2022 and reiterated financial guidance for ...
People also ask
Feb 27, 2024 · 27, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at three upcoming investor conferences in March. ( ...
Find the latest institutional holdings data for Neurocrine Biosciences, Inc. Common Stock (NBIX) including shareholders, ownership summaries, ...
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
According to Zacks Investment Research, based on 11 analysts' forecasts, the consensus EPS forecast for the quarter is $1.05. The reported EPS for the same ...